| Literature DB >> 30573668 |
Jonathan P Bernardini1,2, Jason M Brouwer1,2, Iris Kl Tan1, Jarrod J Sandow1,2, Shuai Huang1,2, Che A Stafford1,2, Aleksandra Bankovacki1, Christopher D Riffkin1, Ahmad Z Wardak1, Peter E Czabotar1,2, Michael Lazarou3, Grant Dewson4,2.
Abstract
The E3 ubiquitin ligase Parkin is a key effector of the removal of damaged mitochondria by mitophagy. Parkin determines cell fate in response to mitochondrial damage, with its loss promoting early onset Parkinson's disease and potentially also cancer progression. Controlling a cell's apoptotic response is essential to co-ordinate the removal of damaged mitochondria. We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove, a region that is crucial for BAK activation by BH3-only proteins and its homo-dimerisation during apoptosis. Ubiquitination inhibited BAK activity by impairing its activation and the formation of lethal BAK oligomers. Parkin also suppresses BAX-mediated apoptosis, but in the absence of BAX ubiquitination suggesting an indirect mechanism. In addition, we find that BAK-dependent mitochondrial outer membrane permeabilisation during apoptosis promotes PINK1-dependent Parkin activation. Hence, we propose that Parkin directly inhibits BAK to suppress errant apoptosis, thereby allowing the effective clearance of damaged mitochondria, but also promotes clearance of apoptotic mitochondria to limit their potential pro-inflammatory effect.Entities:
Keywords: zzm321990BAKzzm321990; zzm321990BAXzzm321990; Parkin; apoptosis; mitophagy
Mesh:
Substances:
Year: 2018 PMID: 30573668 PMCID: PMC6331729 DOI: 10.15252/embj.201899916
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598